lypressin
This page covers all lypressin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Vasopressin receptor.
Targets
Marketed (1)
- Lysipressin · Novartis · Metabolic
Patent intelligence
- lypressin patent landscape — aggregated cliff calendar, attackable patents, originator estates